The trend away from on-site monitoring has resulted in the implementation of alternative monitoring methods, and new approaches such as centralised monitoring processes may complement conventional monitoring. Central data monitoring (CDM) plays an important role here: particularly in large multicentre trials, CDM is not only a highly valuable and often essential addition to on-site monitoring, but it may also help to reduce the number of (cost-intensive) on-site monitoring visits.
To date, a widespread awareness of CDM is lacking, especially in the academic setting of investigator-initiated trials. Therefore, many stakeholders are still unaware of how CDM contributes to data quality and study oversight. Moreover, terminology in guidance documents is inconsistent, and the application of CDM is not clearly described in these documents. To address this lack of harmonised guidance, the SCTO’s Monitoring Platform prepared a fact sheet examining and describing CDM in detail.
As the factsheet is freely accessible to third parties outside the SCTO, you are kindly asked to follow the general instructions on the cover page.
Fact sheets, see images below or download here: https://www.scto.ch/de/network/scto-platforms/monitoring.html
Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.
Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.